Developer docs
API playgroundTry for free, no card

Search company profiles

LucyRx

Full company profile

uuid0005xaq

Namestring
LucyRx
Legal namestring
LucyRx Healthcare Solutions, Inc.
Websiteurl
lucyrx.com
Company typeenum
Private
Founded yearint
2023
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy benefit management, prescription drug benefits, specialty pharmacy services, formulary management, rebate administration
Industry4 codes
PRIMARYHLAEAKAA
Formulary Management & Clinical Pharmacy Programs
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLAEAKAE
Specialty Pharmacy Benefit Management (Specialty PBM)
SECONDARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
NAICS code1 code
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
SIC code1 code
  • Hospital & Medical Service Plans6324
Product category
Pharmacy Benefit Management
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmacy Benefit Management (PBM) Administration
TypeSubscription Recurring
Description

LucyRx operates as a transparent, independent PBM charging administrative fees to plan sponsors (self-insured employers, health plans, TPAs). The model emphasizes full rebate pass-through and no hidden fees, with revenue derived from formulary management, claims processing, network access, and clinical services.

lucyrx.com
2Transparent Rebate Pass-Through
TypeTransaction Fee
Description

Full rebate pass-through model where all manufacturer rebates are passed to plan sponsors, eliminating conflicts of interest. Revenue is generated through transparent administrative fees rather than rebate arbitrage.

lucyrx.com
3Clinical and Specialty Services
TypeSubscription Recurring
Description

Revenue from high-touch clinical services including Care Guide support, specialty pharmacy coordination, GLP-1 management, and women's health benefit programs.

lucyrx.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details2 tiers
1PBM Administration Fees
ModelSubscriptionBilling cadenceAnnual
Notes

Administrative fees charged to plan sponsors for claims processing, formulary management, and network access. Pricing is negotiated per contract and varies by plan size and scope of services. No publicly listed pricing.

lucyrx.com
2Care Guides Plus Program
ModelUsage-basedBilling cadenceMonthly
Notes

$5.00 PMPM (per member per month) for Care Guide clinical support services targeting high-friction, high-cost moments for specialty and chronic therapy management. Estimated $15–$25 PMPM savings across targeted cohorts yielding 2.5–3.0:1 ROI.

lucyrx.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1SPARC
Description

Sustaining Pharmacy Access & Rural Care (SPARC) Program - an initiative to support independent pharmacies in underserved areas by increasing per-prescription reimbursements, expanding community-based healthcare services, and advocating for legislative reforms.

lucyrx.com
+4 more records
Core offering1 text field

LucyRx is an independent, next-generation pharmacy benefit manager (PBM) that administers prescription drug benefits for self-insured employers, health plans, and third-party administrators (TPAs). Its core offering combines transparent claims processing, formulary management via the Unlimited Formulary Marketplace, full rebate pass-through, and clinical support services including Care Guides and the Connected Specialty Care Network, all powered by the proprietary LucyIQ AI analytics platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 15-25% improvement in rebate performance
+9 more records
Product overview1 text field

LucyRx is a next-generation independent pharmacy benefit manager (PBM) offering a unified platform for prescription care management. The core LucyRx Platform integrates with LucyIQ (proprietary AI-powered analytics) to deliver real-time insights, formulary management via the Unlimited Formulary Marketplace, and NDC-level transparency. Clinical support is provided through LucyRx Care Guides (registered nurses, pharmacists, and technicians offering 1:1 member support) and the Connected Specialty Care Network (130+ specialty pharmacies). Specialty modules include GLP-1 Management Solution, Women's Health Benefit for menopause coverage, and Outcomes Accord for performance accountability. The SPARC Program extends support to independent pharmacies in underserved areas. The platform serves plan sponsors, members, and providers with flexible, transparent PBM services.

Product and service9 records
1LucyRx PBM Platform
CategoryPharmacy Benefit Management
2LucyIQ Analytics Platform
CategoryAnalytics Platform
3Connected Specialty Care Network
CategorySpecialty Pharmacy
4Care Guides Plus
CategoryClinical Services
5Unlimited Formulary Marketplace
CategoryFormulary Management
6GLP-1 Management Solution
CategorySpecialty Drug Management
7Women's Health Benefit
CategorySpecialty Benefit Program
8SPARC Program (Sustaining Pharmacy Access & Rural Care)
CategoryPharmacy Network Program
9Outcomes Accord
CategoryPerformance Accountability
Scale indicator19 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

Strategic combination announced June 17, 2026, forming Healthcare Revolution Partners as parent company. Both LucyRx and Abarca become wholly owned subsidiaries. Combined entity serves 9+ million members across commercial and government clients in all 50 states. Merger expected to close Q3 2026 pending regulatory approval. Combines Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-03
Description

LucyRx completed acquisition of CerpassRx (a division of Nomi Health) in Q3 2025, expanding client base and enhancing clinical and cost-containment capabilities. The acquisition integrates CerpassRx's strategies with LucyRx's proprietary AI platform LucyIQ and clinical programs. Both companies continued serving existing clients and members without changes to service or operations following the close.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-11
Description

Strategic partnership announced June 2025 to provide employers with integrated GLP-1 medication and weight care management. Combines LucyRx's pharmacy benefit expertise with Personify's Transform Weight Management program of coach-led counseling and personalized care plans. Partnership includes targeted prior authorization criteria, real-time clinical reviews powered by LucyRx's AI platform LucyIQ, and GLP-1-trained health coaches. An 11,000-life employer group pilot achieved 22-pound average weight loss per member in 12 weeks, 40% medication adherence improvement, $3.2 million in healthcare savings, and 90% member-reported satisfaction.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Capital Rx is an independent, transparent PBM operating the JUDI enterprise platform with NDC-level claims data and pass-through rebate economics — directly comparable to LucyRx's positioning around LucyIQ-driven transparency and formulary flexibility for self-insured employers.

TypeDirect peer
Description

SmithRx is a venture-backed independent PBM focused on self-insured employers with transparent pricing and modern technology. Like LucyRx, it competes on visibility into pharmacy spend and absence of spread pricing, making it a direct SMB/mid-market competitor.

TypeDirect peer
Description

Navitus is a wholly independent (non-vertically-integrated) PBM owned by SSM Health and Costco, serving health plans, employers, and government clients on a 100% pass-through model — the same independent architecture LucyRx sells against the Big Three.

TypeDirect peer
Description

MedImpact is one of the largest independent (non-vertically integrated) PBMs in the U.S., serving health plans, employers, and government programs with transparent, pass-through economics — directly comparable to LucyRx's market positioning.

5EmsanaRx
TypeDirect peer
Description

EmsanaRx is a PBM launched by Emsana (a coalition of large employers) explicitly to provide an independent, transparent alternative for self-insured purchasers — the same employer coalition demand LucyRx targets with its Unlimited Formulary Marketplace.

TypeDirect peer
Description

EmpiRx Health is a smaller independent PBM focused on self-insured employers with a clinical and high-touch member-services model — overlapping with LucyRx's Care Guides and specialty care positioning for mid-market employers.

TypeBroad incumbent
Description

OptumRx is the PBM arm of UnitedHealth Group and one of the 'Big Three' that LucyRx explicitly positions against; it serves a far broader employer, health plan, and government footprint but is constrained by vertical integration that LucyRx markets its independence against.

TypeBroad incumbent
Description

Caremark is the PBM business inside CVS Health, vertically integrated with Aetna and the CVS retail/specialty pharmacy network. It is one of the 'Big Three' PBMs that LucyRx positions its transparent, independent model against in employer RFPs.

TypeBroad incumbent
Description

Express Scripts is the PBM business of The Cigna Group, vertically integrated with Evernorth specialty/accredo services. As one of the 'Big Three' PBMs, it sets the incumbent baseline (scale, integrated specialty) that LucyRx targets with its Connected Specialty Care Network.

TypeBroad incumbent
Description

Humana Pharmacy Solutions is the PBM unit of Humana, focused on Medicare Advantage and integrated commercial business — a broader incumbent that competes against LucyRx for large employer, Medicare, and government carve-in pharmacy benefit contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LucyRx

Pharmacy Benefit Managementlucyrx.com

LucyRx firmographics

Firmographics
Name
LucyRx
Legal name
LucyRx Healthcare Solutions, Inc.
Website
https://lucyrx.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

LucyRx industry classification

Industry
Product category
Pharmacy Benefit Management
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
SIC
Hospital & Medical Service Plans (6324)
akta.pro industry
PRIMARYHLAEAKAA
Formulary Management & Clinical Pharmacy Programs
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLAEAKAE
Specialty Pharmacy Benefit Management (Specialty PBM)
SECONDARYHLAFALAI
Pharmacy Benefit Management (PBM) & Pharmacy Network Administration
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

Keywords

  • Pharmacy benefit management
  • Prescription drug benefits
  • Specialty pharmacy services
  • Formulary management
  • Rebate administration

Where LucyRx is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Offices2 records

Markets served

LucyRx business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Pharmacy Benefit Management (PBM) Administration: LucyRx operates as a transparent, independent PBM charging administrative fees to plan sponsors (self-insured employers, health plans, TPAs). The model emphasizes full rebate pass-through and no hidden fees, with revenue derived from formulary management, claims processing, network access, and clinical services.
  2. Transparent Rebate Pass-Through: Full rebate pass-through model where all manufacturer rebates are passed to plan sponsors, eliminating conflicts of interest. Revenue is generated through transparent administrative fees rather than rebate arbitrage.
  3. Clinical and Specialty Services: Revenue from high-touch clinical services including Care Guide support, specialty pharmacy coordination, GLP-1 management, and women's health benefit programs.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualPBM Administration Fees
Usage-basedMonthlyCare Guides Plus Program

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

LucyRx product offering

Product offering

Core offering

LucyRx is an independent, next-generation pharmacy benefit manager (PBM) that administers prescription drug benefits for self-insured employers, health plans, and third-party administrators (TPAs). Its core offering combines transparent claims processing, formulary management via the Unlimited Formulary Marketplace, full rebate pass-through, and clinical support services including Care Guides and the Connected Specialty Care Network, all powered by the proprietary LucyIQ AI analytics platform.

Product overview

LucyRx is a next-generation independent pharmacy benefit manager (PBM) offering a unified platform for prescription care management. The core LucyRx Platform integrates with LucyIQ (proprietary AI-powered analytics) to deliver real-time insights, formulary management via the Unlimited Formulary Marketplace, and NDC-level transparency. Clinical support is provided through LucyRx Care Guides (registered nurses, pharmacists, and technicians offering 1:1 member support) and the Connected Specialty Care Network (130+ specialty pharmacies). Specialty modules include GLP-1 Management Solution, Women's Health Benefit for menopause coverage, and Outcomes Accord for performance accountability. The SPARC Program extends support to independent pharmacies in underserved areas. The platform serves plan sponsors, members, and providers with flexible, transparent PBM services.

Differentiator

Problem solved

Functional benefit

Brands

  • SPARC: Sustaining Pharmacy Access & Rural Care (SPARC) Program - an initiative to support independent pharmacies in underserved areas by increasing per-prescription reimbursements, expanding community-based healthcare services, and advocating for legislative reforms.
  • LucyRx Women's Health Benefit
  • Outcomes Accord
  • LucyIQ
  • Care Guides

Products and services

  • LucyRx PBM Platform
  • LucyIQ Analytics Platform
  • Connected Specialty Care Network
  • Care Guides Plus
  • Unlimited Formulary Marketplace
  • GLP-1 Management Solution
  • Women's Health Benefit
  • SPARC Program (Sustaining Pharmacy Access & Rural Care)
  • Outcomes Accord

Quantifiable outcome

  • 15-25% improvement in rebate performance
  • +9 more outcomes

Companies that use LucyRx

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

LucyRx technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

LucyRx partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • Abarca HealthflagshipStrategic or Co-development Partner · 17 June 2026Strategic combination announced June 17, 2026, forming Healthcare Revolution Partners as parent company. Both LucyRx and Abarca become wholly owned subsidiaries. Combined entity serves 9+ million members across commercial and government clients in all 50 states. Merger expected to close Q3 2026 pending regulatory approval. Combines Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network.
  • CerpassRx (division of Nomi Health)coreStrategic or Co-development Partner · 3 October 2025LucyRx completed acquisition of CerpassRx (a division of Nomi Health) in Q3 2025, expanding client base and enhancing clinical and cost-containment capabilities. The acquisition integrates CerpassRx's strategies with LucyRx's proprietary AI platform LucyIQ and clinical programs. Both companies continued serving existing clients and members without changes to service or operations following the close.
  • Personify HealthcoreStrategic or Co-development Partner · 11 June 2025Strategic partnership announced June 2025 to provide employers with integrated GLP-1 medication and weight care management. Combines LucyRx's pharmacy benefit expertise with Personify's Transform Weight Management program of coach-led counseling and personalized care plans. Partnership includes targeted prior authorization criteria, real-time clinical reviews powered by LucyRx's AI platform LucyIQ, and GLP-1-trained health coaches. An 11,000-life employer group pilot achieved 22-pound average weight loss per member in 12 weeks, 40% medication adherence improvement, $3.2 million in healthcare savings, and 90% member-reported satisfaction.

Scale indicators19 records

Recent moves8 records

Expansion highlights7 records

LucyRx competitors and assessment

Company assessment

Direct peers

  • Capital Rx: Capital Rx is an independent, transparent PBM operating the JUDI enterprise platform with NDC-level claims data and pass-through rebate economics — directly comparable to LucyRx's positioning around LucyIQ-driven transparency and formulary flexibility for self-insured employers.
  • SmithRx: SmithRx is a venture-backed independent PBM focused on self-insured employers with transparent pricing and modern technology. Like LucyRx, it competes on visibility into pharmacy spend and absence of spread pricing, making it a direct SMB/mid-market competitor.
  • Navitus Health Solutions: Navitus is a wholly independent (non-vertically-integrated) PBM owned by SSM Health and Costco, serving health plans, employers, and government clients on a 100% pass-through model — the same independent architecture LucyRx sells against the Big Three.
  • MedImpact Healthcare Systems: MedImpact is one of the largest independent (non-vertically integrated) PBMs in the U.S., serving health plans, employers, and government programs with transparent, pass-through economics — directly comparable to LucyRx's market positioning.
  • EmsanaRx: EmsanaRx is a PBM launched by Emsana (a coalition of large employers) explicitly to provide an independent, transparent alternative for self-insured purchasers — the same employer coalition demand LucyRx targets with its Unlimited Formulary Marketplace.
  • EmpiRx Health: EmpiRx Health is a smaller independent PBM focused on self-insured employers with a clinical and high-touch member-services model — overlapping with LucyRx's Care Guides and specialty care positioning for mid-market employers.

Broad incumbents

  • OptumRx (UnitedHealth Group): OptumRx is the PBM arm of UnitedHealth Group and one of the 'Big Three' that LucyRx explicitly positions against; it serves a far broader employer, health plan, and government footprint but is constrained by vertical integration that LucyRx markets its independence against.
  • CVS Caremark (CVS Health): Caremark is the PBM business inside CVS Health, vertically integrated with Aetna and the CVS retail/specialty pharmacy network. It is one of the 'Big Three' PBMs that LucyRx positions its transparent, independent model against in employer RFPs.
  • Express Scripts (Cigna Group): Express Scripts is the PBM business of The Cigna Group, vertically integrated with Evernorth specialty/accredo services. As one of the 'Big Three' PBMs, it sets the incumbent baseline (scale, integrated specialty) that LucyRx targets with its Connected Specialty Care Network.
  • Humana Pharmacy Solutions: Humana Pharmacy Solutions is the PBM unit of Humana, focused on Medicare Advantage and integrated commercial business — a broader incumbent that competes against LucyRx for large employer, Medicare, and government carve-in pharmacy benefit contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights6 records

Customer concentration

LucyRx social profiles

Digital presence

LucyRx compliance and trust

Trust signal

Compliance3 records

LucyRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LucyRx leadership team

Management profile

Number of profiles

Profiles9 records

LucyRx subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

LucyRx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LucyRx M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LucyRx

What does LucyRx do?

LucyRx is an independent, next-generation pharmacy benefit manager (PBM) that administers prescription drug benefits for self-insured employers, health plans, and third-party administrators (TPAs). Its core offering combines transparent claims processing, formulary management via the Unlimited Formulary Marketplace, full rebate pass-through, and clinical support services including Care Guides and the Connected Specialty Care Network, all powered by the proprietary LucyIQ AI analytics platform.

Is LucyRx a public or private company?

LucyRx is a private company. It is classified as venture growth investor backed and is currently operating.

When was LucyRx founded?

LucyRx was founded in 2023. It employs 101 to 250 people.

Where is LucyRx based?

LucyRx is headquartered in Bethesda, United States, in the North America region.

How does LucyRx make money?

Three revenue lines are on record. Pharmacy Benefit Management (PBM) Administration is the primary driver. The others are transparent Rebate Pass-Through and clinical and Specialty Services.

Who are LucyRx's main competitors?

Direct peers on record are Capital Rx, SmithRx, Navitus Health Solutions, MedImpact Healthcare Systems, EmsanaRx and EmpiRx Health. Broad incumbents are OptumRx (UnitedHealth Group), CVS Caremark (CVS Health), Express Scripts (Cigna Group) and Humana Pharmacy Solutions.

Does LucyRx have an API?

Yes. LucyRx maintains internal APIs used by authorized customers for platform access. The Platform Terms of Use reference 'application programming interfaces (APIs)' as part of the licensed use restrictions, indicating an API exists for authorized customer use. The specific API type (REST, GraphQL, etc.), authentication method, documentation URL, and SDK availability are not specified in the provided source material.

What industry is LucyRx in?

LucyRx's product category is Pharmacy Benefit Management. Its primary akta.pro industry code is HLAEAKAA, Formulary Management & Clinical Pharmacy Programs, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 524292 and its SIC code is 6324.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ModernhealthcarePBMs pitch employers bold ways to lower drug costs - Modern HealthcarePharmacy benefit managers are developing new strategies to help employers contain rising pharmaceutical costs, with novel sales pitches being offered in a competitive market. MedImpact and LucyRx are among the PBMs actively acquiring smaller competitors to expand their capabilities and better serve employers. The FTC has been investigating the largest PBMs, including CVS Health, for allegedly inflating insulin drug prices.FierceHealthcareAs PBM industry shifts, LucyRx and Abarca Health merge to build scaleLucyRx and Abarca Health announced plans to merge, creating Healthcare Revolution Partners as their parent organization, with the deal expected to close in Q3 2026 pending regulatory approval. The combined organization will serve more than 9 million members across the country. The merger aims to build the scale necessary to compete as rising healthcare costs, particularly around GLP-1 drugs, push more employers and plans to seek alternatives to traditional vertically integrated PBMs.MedCity NewsAbarca Health and LucyRx to Combine to Scale Independent PBM ModelAbarca Health and LucyRx announced they are combining to form an independent pharmacy benefit manager under parent company Healthcare Revolution Partners, supporting over 9 million members across commercial and government clients. The merger, pending regulatory approval and expected to close in Q3 2026, positions the combined entity to compete against the dominant "Big Three" PBMs as the industry faces increased federal and state scrutiny and reform. The companies view the regulatory changes, including the Consolidated Appropriations Act of 2026 and state-level PBM legislation, as a disruptive tailwind favoring independent players.YahooMerger Of Abarca And LucyRx May Not Be The Last PBM Deal This YearIndependent pharmacy benefit managers Abarca Health and LucyRx announced a merger on June 17, 2026, creating a combined entity serving more than 9 million plan members across the United States. The deal positions the merged company as a scaled alternative to the three dominant PBMs—CVS Health's Caremark, Express Scripts, and OptumRx—which together control approximately 80% of the U.S. market. Industry analysts predict that increasing regulatory complexity will drive further consolidation among smaller PBMs, as these companies lack the capital and infrastructure to absorb compliance costs while maintaining competitive prescription drug pricing.ForbesMerger Of Abarca And LucyRx May Not Be The Last PBM Deal This YearAbarca Health and LucyRx, two independent pharmacy benefit management companies, have agreed to merge to form Healthcare Revolution Partners, creating a combined entity that will serve more than 9 million plan members across the U.S. The deal, announced June 17, 2026 and expected to close in Q3 pending regulatory approval, aims to position the merged company as a competitive alternative to the three largest PBMs that control 80% of the U.S. market. Industry analysts predict the regulatory and competitive pressures driving this merger will lead to further consolidation among smaller PBMs over the next five years.BioSpaceAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to form the only modern, independent pharmacy benefit manager capable of serving commercial and government clients at scale. The combined entity will serve over 9 million members in the United States and operate as wholly owned subsidiaries of Healthcare Revolution Partners pending regulatory approval expected in Q3 2026. This merger aims to leverage Abarca's technology platform and LucyRx's clinical capabilities to address rising drug costs and evolving regulatory demands.AijournAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to form a modern, independent pharmacy benefit manager under Healthcare Revolution Partners, creating an entity serving over 9 million members across the United States. The combined company will maintain both brands as wholly owned subsidiaries while expanding capabilities to serve both commercial and government clients at scale. The transaction is expected to close in Q3 2026, pending regulatory approvals, with current leadership continuing in their respective roles.PR NewswireAbarca Health and LucyRx Announce Strategic Combination to Create the Only Modern PBM Built for Commercial and Government ScaleAbarca Health and LucyRx announced a strategic combination to create a modern, independent pharmacy benefit manager (PBM) serving both commercial and government clients, with the combined entity operating as subsidiaries of newly formed Healthcare Revolution Partners. The merged company will provide prescription services to more than 9 million members across the United States and bring together Abarca's Darwin Healthcare Intelligence platform with LucyRx's clinical capabilities and Connected Specialty Care Network. The transaction, expected to close in Q3 2026, is subject to regulatory approvals and customary closing conditions, with both companies remaining independently owned and operated until closing.ForbesAbarca Health And LucyRx To Merge Into Alternative To Big Three PBMsAbarca Health and LucyRx, two privately held independent pharmacy benefit management companies, have agreed to merge as an alternative to the nation\'s three largest PBMs that control 80% of the U.S. market. The combined entity will serve more than 9 million plan members across all 50 states under the new parent company Healthcare Revolution Partners, with the deal expected to close in Q3 2026 pending regulatory approvals. The merger positions the companies as a transparent, non-vertically integrated option at a time when PBMs face unprecedented regulatory scrutiny and pressure from policymakers seeking lower prescription drug prices.AbarcahealthAbarca Health and LucyRx Announce Strategic CombinationAbarca Health and LucyRx announced a strategic combination to create a modern independent pharmacy benefit manager. The combined entity will serve over 9 million members across the U.S., with the deal expected to close in the third quarter of 2026.